1. Medtech Insight
  2. >>Device Area
  3. >>Orthopedics

Market Intel: Market Dynamics Switchover To Come In Fast-Growing Soft Tissue Fixation Segment

 
• By Marion Webb

Global sales for arthroscopy and sports medicine devices are predicted to hit $6.5bn by 2021. This will be driven by the fast-growing soft tissue fixation products segment: significant changes in market dynamics are expected over the next few years, as hip fixation procedures pick up pace. This article delves into the landscape of the soft tissue fixation device market, as well as the four key segments in the arthroscopy devices space. It will also analyze the key players in these markets, highlight trends and discuss the biggest challenges.

Arthroscopy_1200x675

Global sales for arthroscopy and sports medicine devices are expected to reach $6.5bn by 2021, representing a CAGR of 4.1%. Of the two main market segments, soft tissue fixation products and arthroscopy devices, soft tissue fixation represented the smaller segment with 35.7% market share in 2016 vs. 64.3% for arthroscopy devices. However, it will see the most significant growth over the next few years.

According to a new report by Meddevicetracker, "Global Market for Arthroscopy and Sports Medicine Devices", worldwide sales of soft tissue...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Orthopedics

More from Device Area

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By Elizabeth Orr

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.

Philips Deals Itself A Strong Hand In POCUS Stakes

 
• By Ashley Yeo

Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 
• By Natasha Barrow

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.